Jeffrey E. Jacob - Jun 15, 2022 Form 3 Insider Report for Panbela Therapeutics, Inc. (PBLA)

Role
Director
Signature
/s/ Joshua L. Colburn, Attorney-in-Fact
Stock symbol
PBLA
Transactions as of
Jun 15, 2022
Transactions value $
$0
Form type
3
Date filed
6/27/2022, 08:44 AM
Next filing
Oct 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PBLA Common Stock 262K Jun 15, 2022 Direct
holding PBLA Common Stock 17.8K Jun 15, 2022 Jointly with spouse
holding PBLA Common Stock 54.4K Jun 15, 2022 By trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PBLA Stock Option (right to buy) Jun 15, 2022 Common Stock 41.8K $1.24 Direct F1
holding PBLA Stock Option (right to buy) Jun 15, 2022 Common Stock 35.5K $1.47 Direct F1
holding PBLA Stock Option (right to buy) Jun 15, 2022 Common Stock 91.5K $0.22 Direct F1
holding PBLA Stock Option (right to buy) Jun 15, 2022 Common Stock 178K $0.22 Direct F1
holding PBLA Warrants (right to buy) Jun 15, 2022 Common Stock 5.17K $5.63 By trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested.

Remarks:

Exhibit List: Power for Attorney EX-24